A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China.

Zhang, Zizhu; Chong, Yizheng; Liu, Yuanhao; Pan, Jianji; Huang, Cheng; Sun, Qi; Liu, Zhibo; Zhu, Xiayang; Shao, Yujun; Jin, Congjun; Liu, Tong

Zhang, Zizhu; Chong, Yizheng; Liu, Yuanhao; Pan, Jianji; Huang, Cheng; Sun, Qi; Liu, Zhibo; Zhu, Xiayang; Shao, Yujun; Jin, Congjun; Liu, Tong.

Afiliação

Zhang Z; Beijing Nuclear Industry Hospital, Beijing 102413, China.
Chong Y; Beijing Capture Tech Co., Ltd., Beijing 102413, China.
Liu Y; Innovation Business Center, China National Nuclear Corporation Overseas Ltd., Beijing 100044, China.
Pan J; Neuboron Therapy System Ltd., Nanjing 211100, China.
Huang C; BNCT Center, Xiamen Humanity Hospital, Xiamen 361016, China.
Sun Q; BNCT Center, Xiamen Humanity Hospital, Xiamen 361016, China.
Liu Z; BNCT Center, Xiamen Humanity Hospital, Xiamen 361016, China.
Zhu X; College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
Shao Y; College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China.
Jin C; Beijing Nuclear Industry Hospital, Beijing 102413, China.
Liu T; Beijing Nuclear Industry Hospital, Beijing 102413, China.

Cancers (Basel) ; 15(16)2023 Aug 11.

Article em En | MEDLINE | ID: mdl-37627088

Palavras-chave

BNCT; IHNI-1; NeuPex; boron agents; neutron source

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google